Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines

The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from Erwinia carotovora (ECAR LANS) and Escherichia coli (MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry Biomedical chemistry, 2012-10, Vol.6 (4), p.307-316
Hauptverfasser: Abakumova, O. Yu, Podobed, O. V., Karalkin, P. A., Kondakova, L. I., Sokolov, N. N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 316
container_issue 4
container_start_page 307
container_title Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry
container_volume 6
creator Abakumova, O. Yu
Podobed, O. V.
Karalkin, P. A.
Kondakova, L. I.
Sokolov, N. N.
description The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from Erwinia carotovora (ECAR LANS) and Escherichia coli (MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lines (Jurkat, Jurkat/A4, Molt-4), human chronic myeloid leukemia K562 cells, human promyelocytic leukemia HL-60, and also human solid tumor cells (prostate carcinoma LnCap, breast adenocarcinoma MCF7, ovarian adenocarcinoma SCOV-3 and carcinoma CaOV, hepatocarcinoma Hep G2, fibrosarcoma HT-1080) and animal solid tumor cells (rat Gasser’s ganglion neurinoma cells GGNC-1, mouse glioblastoma EPNT-5). We investigated sensitivity of tumor cells (seeded at different density) to L-asparaginases, as well the effect of L-asparaginases on cell growth rate, protein and DNA synthesis in the presence of various cytostatics. Cell cycle analysis by flow cytofluorimetry and detection of apoptotic cells before and after treatment with L-asparaginases indicate that ECAR LANS L-asparaginase suppressed growth of all tested solid tumor cells. Evaluation of leukemic cell number after treatment with L-asparaginases for 24, 48 and 72 h demonstrated that asparagine deficiency did not kill cells but stopped normal cell division. The cytofluorometric study of solid and leukemic cells revealed that except HL-60 cells the treatment with L-asparaginase for 72 h did not change cell cycle phase distribution and did not increase the number of apoptotic cells. Combined treatment of cells using a combination of L-asparaginase and doxorubicin significantly increased the number of apoptotic cells up to 60% (MCF-7 cells), 40% (Jurkat cells) and even 99% (HL-60). High levels of DNA and protein synthesis rates in asparaginase-treated tumor cells suggest lack of massive entry of tumor cells to apoptosis. This conclusion is based on the fact of sensitivity of multi-resistant Jurkat/A4 cells to L-asparaginases (it is nearly impossible to induce apoptosis in these cells). Since ECAR LANS did not influence growth of normal human fibroblasts it appears that the enzyme cytotoxicity is associated only asparagine deficiency.
doi_str_mv 10.1134/S1990750812040026
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1285088704</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2815149431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c349t-f9c288fefbe5e3b82b245b19a702595de8497f585872e9d944eb4f409647327f3</originalsourceid><addsrcrecordid>eNp1kU1PxCAQhhujibr6A7yRePFSBQoLHI3xK9nEg3puaDusrC2sQDV79o_LusYYjQcyZHjed4aZojgi-JSQip3dE6Ww4FgSihnGdLpV7K1TpeBkuv19x3K32I9xgfGUVIrtFe_nLtk0Dj4g3Sb7atMKeYNmpY5LHfTcOh0BmeAHdBnerLMatTr45F990EjPtXUxoc4aAwFcQk_joB3SrsvHDrpHPYzPMNj2Mxd9bzu0KddCn1-tg3hQ7BjdRzj8ipPi8ery4eKmnN1d316cz8q2YiqVRrVUSgOmAQ5VI2lDGW-I0gJTrngHkilhuORSUFCdYgwaZhhWUyYqKkw1KU42vsvgX0aIqR5sXLehHfgx1oTKPCApMMvo8S904cfgcnc1IZwIpQhRmSIbqg0-xgCmXob86bCqCa7Xa6n_rCVr6EYTM-vmEH44_yv6ALL2j_M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1151799119</pqid></control><display><type>article</type><title>Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines</title><source>SpringerLink Journals - AutoHoldings</source><creator>Abakumova, O. Yu ; Podobed, O. V. ; Karalkin, P. A. ; Kondakova, L. I. ; Sokolov, N. N.</creator><creatorcontrib>Abakumova, O. Yu ; Podobed, O. V. ; Karalkin, P. A. ; Kondakova, L. I. ; Sokolov, N. N.</creatorcontrib><description>The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from Erwinia carotovora (ECAR LANS) and Escherichia coli (MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lines (Jurkat, Jurkat/A4, Molt-4), human chronic myeloid leukemia K562 cells, human promyelocytic leukemia HL-60, and also human solid tumor cells (prostate carcinoma LnCap, breast adenocarcinoma MCF7, ovarian adenocarcinoma SCOV-3 and carcinoma CaOV, hepatocarcinoma Hep G2, fibrosarcoma HT-1080) and animal solid tumor cells (rat Gasser’s ganglion neurinoma cells GGNC-1, mouse glioblastoma EPNT-5). We investigated sensitivity of tumor cells (seeded at different density) to L-asparaginases, as well the effect of L-asparaginases on cell growth rate, protein and DNA synthesis in the presence of various cytostatics. Cell cycle analysis by flow cytofluorimetry and detection of apoptotic cells before and after treatment with L-asparaginases indicate that ECAR LANS L-asparaginase suppressed growth of all tested solid tumor cells. Evaluation of leukemic cell number after treatment with L-asparaginases for 24, 48 and 72 h demonstrated that asparagine deficiency did not kill cells but stopped normal cell division. The cytofluorometric study of solid and leukemic cells revealed that except HL-60 cells the treatment with L-asparaginase for 72 h did not change cell cycle phase distribution and did not increase the number of apoptotic cells. Combined treatment of cells using a combination of L-asparaginase and doxorubicin significantly increased the number of apoptotic cells up to 60% (MCF-7 cells), 40% (Jurkat cells) and even 99% (HL-60). High levels of DNA and protein synthesis rates in asparaginase-treated tumor cells suggest lack of massive entry of tumor cells to apoptosis. This conclusion is based on the fact of sensitivity of multi-resistant Jurkat/A4 cells to L-asparaginases (it is nearly impossible to induce apoptosis in these cells). Since ECAR LANS did not influence growth of normal human fibroblasts it appears that the enzyme cytotoxicity is associated only asparagine deficiency.</description><identifier>ISSN: 1990-7508</identifier><identifier>EISSN: 1990-7516</identifier><identifier>DOI: 10.1134/S1990750812040026</identifier><language>eng</language><publisher>Dordrecht: SP MAIK Nauka/Interperiodica</publisher><subject>Acute lymphatic leukemia ; Adenocarcinoma ; Antitumor activity ; Apoptosis ; Asparagine ; Biochemistry ; Bioorganic Chemistry ; Cancer ; Cell cycle ; Cell division ; Cell number ; Chemistry ; Chemistry and Materials Science ; Chemotherapy ; Chronic myeloid leukemia ; Cytotoxicity ; Deoxyribonucleic acid ; DNA ; DNA biosynthesis ; Doxorubicin ; Enzymes ; Erwinia carotovora ; Escherichia coli ; Fibroblasts ; Fibrosarcoma ; Glioblastoma ; Growth rate ; L-asparaginase ; Leukemia ; Lymphocytes T ; Medicinal Chemistry ; Promyeloid leukemia ; prostate carcinoma ; Protein biosynthesis ; Protein synthesis ; Solid tumors ; Tumor cell lines ; Tumor cells</subject><ispartof>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry, 2012-10, Vol.6 (4), p.307-316</ispartof><rights>Pleiades Publishing, Ltd. 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c349t-f9c288fefbe5e3b82b245b19a702595de8497f585872e9d944eb4f409647327f3</citedby><cites>FETCH-LOGICAL-c349t-f9c288fefbe5e3b82b245b19a702595de8497f585872e9d944eb4f409647327f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S1990750812040026$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S1990750812040026$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Abakumova, O. Yu</creatorcontrib><creatorcontrib>Podobed, O. V.</creatorcontrib><creatorcontrib>Karalkin, P. A.</creatorcontrib><creatorcontrib>Kondakova, L. I.</creatorcontrib><creatorcontrib>Sokolov, N. N.</creatorcontrib><title>Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines</title><title>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</title><addtitle>Biochem. Moscow Suppl. Ser. B</addtitle><description>The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from Erwinia carotovora (ECAR LANS) and Escherichia coli (MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lines (Jurkat, Jurkat/A4, Molt-4), human chronic myeloid leukemia K562 cells, human promyelocytic leukemia HL-60, and also human solid tumor cells (prostate carcinoma LnCap, breast adenocarcinoma MCF7, ovarian adenocarcinoma SCOV-3 and carcinoma CaOV, hepatocarcinoma Hep G2, fibrosarcoma HT-1080) and animal solid tumor cells (rat Gasser’s ganglion neurinoma cells GGNC-1, mouse glioblastoma EPNT-5). We investigated sensitivity of tumor cells (seeded at different density) to L-asparaginases, as well the effect of L-asparaginases on cell growth rate, protein and DNA synthesis in the presence of various cytostatics. Cell cycle analysis by flow cytofluorimetry and detection of apoptotic cells before and after treatment with L-asparaginases indicate that ECAR LANS L-asparaginase suppressed growth of all tested solid tumor cells. Evaluation of leukemic cell number after treatment with L-asparaginases for 24, 48 and 72 h demonstrated that asparagine deficiency did not kill cells but stopped normal cell division. The cytofluorometric study of solid and leukemic cells revealed that except HL-60 cells the treatment with L-asparaginase for 72 h did not change cell cycle phase distribution and did not increase the number of apoptotic cells. Combined treatment of cells using a combination of L-asparaginase and doxorubicin significantly increased the number of apoptotic cells up to 60% (MCF-7 cells), 40% (Jurkat cells) and even 99% (HL-60). High levels of DNA and protein synthesis rates in asparaginase-treated tumor cells suggest lack of massive entry of tumor cells to apoptosis. This conclusion is based on the fact of sensitivity of multi-resistant Jurkat/A4 cells to L-asparaginases (it is nearly impossible to induce apoptosis in these cells). Since ECAR LANS did not influence growth of normal human fibroblasts it appears that the enzyme cytotoxicity is associated only asparagine deficiency.</description><subject>Acute lymphatic leukemia</subject><subject>Adenocarcinoma</subject><subject>Antitumor activity</subject><subject>Apoptosis</subject><subject>Asparagine</subject><subject>Biochemistry</subject><subject>Bioorganic Chemistry</subject><subject>Cancer</subject><subject>Cell cycle</subject><subject>Cell division</subject><subject>Cell number</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Chemotherapy</subject><subject>Chronic myeloid leukemia</subject><subject>Cytotoxicity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA biosynthesis</subject><subject>Doxorubicin</subject><subject>Enzymes</subject><subject>Erwinia carotovora</subject><subject>Escherichia coli</subject><subject>Fibroblasts</subject><subject>Fibrosarcoma</subject><subject>Glioblastoma</subject><subject>Growth rate</subject><subject>L-asparaginase</subject><subject>Leukemia</subject><subject>Lymphocytes T</subject><subject>Medicinal Chemistry</subject><subject>Promyeloid leukemia</subject><subject>prostate carcinoma</subject><subject>Protein biosynthesis</subject><subject>Protein synthesis</subject><subject>Solid tumors</subject><subject>Tumor cell lines</subject><subject>Tumor cells</subject><issn>1990-7508</issn><issn>1990-7516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kU1PxCAQhhujibr6A7yRePFSBQoLHI3xK9nEg3puaDusrC2sQDV79o_LusYYjQcyZHjed4aZojgi-JSQip3dE6Ww4FgSihnGdLpV7K1TpeBkuv19x3K32I9xgfGUVIrtFe_nLtk0Dj4g3Sb7atMKeYNmpY5LHfTcOh0BmeAHdBnerLMatTr45F990EjPtXUxoc4aAwFcQk_joB3SrsvHDrpHPYzPMNj2Mxd9bzu0KddCn1-tg3hQ7BjdRzj8ipPi8ery4eKmnN1d316cz8q2YiqVRrVUSgOmAQ5VI2lDGW-I0gJTrngHkilhuORSUFCdYgwaZhhWUyYqKkw1KU42vsvgX0aIqR5sXLehHfgx1oTKPCApMMvo8S904cfgcnc1IZwIpQhRmSIbqg0-xgCmXob86bCqCa7Xa6n_rCVr6EYTM-vmEH44_yv6ALL2j_M</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Abakumova, O. Yu</creator><creator>Podobed, O. V.</creator><creator>Karalkin, P. A.</creator><creator>Kondakova, L. I.</creator><creator>Sokolov, N. N.</creator><general>SP MAIK Nauka/Interperiodica</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20121001</creationdate><title>Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines</title><author>Abakumova, O. Yu ; Podobed, O. V. ; Karalkin, P. A. ; Kondakova, L. I. ; Sokolov, N. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c349t-f9c288fefbe5e3b82b245b19a702595de8497f585872e9d944eb4f409647327f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute lymphatic leukemia</topic><topic>Adenocarcinoma</topic><topic>Antitumor activity</topic><topic>Apoptosis</topic><topic>Asparagine</topic><topic>Biochemistry</topic><topic>Bioorganic Chemistry</topic><topic>Cancer</topic><topic>Cell cycle</topic><topic>Cell division</topic><topic>Cell number</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Chemotherapy</topic><topic>Chronic myeloid leukemia</topic><topic>Cytotoxicity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA biosynthesis</topic><topic>Doxorubicin</topic><topic>Enzymes</topic><topic>Erwinia carotovora</topic><topic>Escherichia coli</topic><topic>Fibroblasts</topic><topic>Fibrosarcoma</topic><topic>Glioblastoma</topic><topic>Growth rate</topic><topic>L-asparaginase</topic><topic>Leukemia</topic><topic>Lymphocytes T</topic><topic>Medicinal Chemistry</topic><topic>Promyeloid leukemia</topic><topic>prostate carcinoma</topic><topic>Protein biosynthesis</topic><topic>Protein synthesis</topic><topic>Solid tumors</topic><topic>Tumor cell lines</topic><topic>Tumor cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abakumova, O. Yu</creatorcontrib><creatorcontrib>Podobed, O. V.</creatorcontrib><creatorcontrib>Karalkin, P. A.</creatorcontrib><creatorcontrib>Kondakova, L. I.</creatorcontrib><creatorcontrib>Sokolov, N. N.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abakumova, O. Yu</au><au>Podobed, O. V.</au><au>Karalkin, P. A.</au><au>Kondakova, L. I.</au><au>Sokolov, N. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines</atitle><jtitle>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</jtitle><stitle>Biochem. Moscow Suppl. Ser. B</stitle><date>2012-10-01</date><risdate>2012</risdate><volume>6</volume><issue>4</issue><spage>307</spage><epage>316</epage><pages>307-316</pages><issn>1990-7508</issn><eissn>1990-7516</eissn><abstract>The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from Erwinia carotovora (ECAR LANS) and Escherichia coli (MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lines (Jurkat, Jurkat/A4, Molt-4), human chronic myeloid leukemia K562 cells, human promyelocytic leukemia HL-60, and also human solid tumor cells (prostate carcinoma LnCap, breast adenocarcinoma MCF7, ovarian adenocarcinoma SCOV-3 and carcinoma CaOV, hepatocarcinoma Hep G2, fibrosarcoma HT-1080) and animal solid tumor cells (rat Gasser’s ganglion neurinoma cells GGNC-1, mouse glioblastoma EPNT-5). We investigated sensitivity of tumor cells (seeded at different density) to L-asparaginases, as well the effect of L-asparaginases on cell growth rate, protein and DNA synthesis in the presence of various cytostatics. Cell cycle analysis by flow cytofluorimetry and detection of apoptotic cells before and after treatment with L-asparaginases indicate that ECAR LANS L-asparaginase suppressed growth of all tested solid tumor cells. Evaluation of leukemic cell number after treatment with L-asparaginases for 24, 48 and 72 h demonstrated that asparagine deficiency did not kill cells but stopped normal cell division. The cytofluorometric study of solid and leukemic cells revealed that except HL-60 cells the treatment with L-asparaginase for 72 h did not change cell cycle phase distribution and did not increase the number of apoptotic cells. Combined treatment of cells using a combination of L-asparaginase and doxorubicin significantly increased the number of apoptotic cells up to 60% (MCF-7 cells), 40% (Jurkat cells) and even 99% (HL-60). High levels of DNA and protein synthesis rates in asparaginase-treated tumor cells suggest lack of massive entry of tumor cells to apoptosis. This conclusion is based on the fact of sensitivity of multi-resistant Jurkat/A4 cells to L-asparaginases (it is nearly impossible to induce apoptosis in these cells). Since ECAR LANS did not influence growth of normal human fibroblasts it appears that the enzyme cytotoxicity is associated only asparagine deficiency.</abstract><cop>Dordrecht</cop><pub>SP MAIK Nauka/Interperiodica</pub><doi>10.1134/S1990750812040026</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1990-7508
ispartof Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry, 2012-10, Vol.6 (4), p.307-316
issn 1990-7508
1990-7516
language eng
recordid cdi_proquest_miscellaneous_1285088704
source SpringerLink Journals - AutoHoldings
subjects Acute lymphatic leukemia
Adenocarcinoma
Antitumor activity
Apoptosis
Asparagine
Biochemistry
Bioorganic Chemistry
Cancer
Cell cycle
Cell division
Cell number
Chemistry
Chemistry and Materials Science
Chemotherapy
Chronic myeloid leukemia
Cytotoxicity
Deoxyribonucleic acid
DNA
DNA biosynthesis
Doxorubicin
Enzymes
Erwinia carotovora
Escherichia coli
Fibroblasts
Fibrosarcoma
Glioblastoma
Growth rate
L-asparaginase
Leukemia
Lymphocytes T
Medicinal Chemistry
Promyeloid leukemia
prostate carcinoma
Protein biosynthesis
Protein synthesis
Solid tumors
Tumor cell lines
Tumor cells
title Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T15%3A59%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antitumor%20activity%20of%20L-asparaginase%20from%20Erwinia%20carotovora%20against%20different%20human%20and%20animal%20leukemic%20and%20solid%20tumor%20cell%20lines&rft.jtitle=Biochemistry%20(Moscow).%20Supplement.%20Series%20B,%20Biomedical%20chemistry&rft.au=Abakumova,%20O.%20Yu&rft.date=2012-10-01&rft.volume=6&rft.issue=4&rft.spage=307&rft.epage=316&rft.pages=307-316&rft.issn=1990-7508&rft.eissn=1990-7516&rft_id=info:doi/10.1134/S1990750812040026&rft_dat=%3Cproquest_cross%3E2815149431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1151799119&rft_id=info:pmid/&rfr_iscdi=true